NO914968L - Benzodiazepinoner - Google Patents

Benzodiazepinoner

Info

Publication number
NO914968L
NO914968L NO91914968A NO914968A NO914968L NO 914968 L NO914968 L NO 914968L NO 91914968 A NO91914968 A NO 91914968A NO 914968 A NO914968 A NO 914968A NO 914968 L NO914968 L NO 914968L
Authority
NO
Norway
Prior art keywords
benzodiazepinones
Prior art date
Application number
NO91914968A
Other languages
English (en)
Norwegian (no)
Other versions
NO914968D0 (no
Inventor
Ming-Chu Hsu
Donna Mary Huryn
Steve Yik-Kai Tam
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO914968D0 publication Critical patent/NO914968D0/no
Publication of NO914968L publication Critical patent/NO914968L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO91914968A 1990-12-17 1991-12-16 Benzodiazepinoner NO914968L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62855190A 1990-12-17 1990-12-17

Publications (2)

Publication Number Publication Date
NO914968D0 NO914968D0 (no) 1991-12-16
NO914968L true NO914968L (no) 1992-06-18

Family

ID=24519378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914968A NO914968L (no) 1990-12-17 1991-12-16 Benzodiazepinoner

Country Status (18)

Country Link
EP (1) EP0491218A1 (cs)
JP (1) JPH04275287A (cs)
KR (1) KR920012070A (cs)
CN (1) CN1062528A (cs)
AU (1) AU8974191A (cs)
BR (1) BR9105406A (cs)
CA (1) CA2057646A1 (cs)
CS (1) CS381891A3 (cs)
FI (1) FI915915A7 (cs)
HU (1) HUT59920A (cs)
IE (1) IE914369A1 (cs)
IL (1) IL100364A0 (cs)
IS (1) IS3792A7 (cs)
MX (1) MX9102580A (cs)
NO (1) NO914968L (cs)
PT (1) PT99821A (cs)
YU (1) YU194691A (cs)
ZA (1) ZA919850B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221687B (cs) * 1992-01-24 1994-03-11 Hoffmann La Roche
CA2106387A1 (en) * 1992-02-26 1993-08-27 F. Hoffmann-La Roche Ag Benzodiazepinones
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
JP3647451B2 (ja) * 1993-09-30 2005-05-11 塩野義製薬株式会社 ベンゾラクタム誘導体
IT1297090B1 (it) * 1997-12-01 1999-08-03 Barbara Ensoli Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le
DE19920955C2 (de) * 1999-05-06 2002-11-28 Wacker Chemie Gmbh 2-(Benz-)Imidazol-,2-(Benz-)Oxazol- und 2-(Benz-)Thiazol-substituierte Silane und Verfahren zu deren Herstellung
NZ538870A (en) 2002-09-20 2007-04-27 Arrow Therapeutics Ltd Benzodiazepine derivatives and pharmaceutical compositions containing them
CA2529227A1 (en) * 2003-06-26 2005-01-06 Merck & Co., Inc. Benzodiazepine cgrp receptor antagonists
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406282D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
BRPI0520554A2 (pt) 2005-09-19 2009-06-13 Arrow Therapeutics Ltd uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica
WO2007110337A1 (en) 2006-03-29 2007-10-04 F. Hoffmann-La Roche Ag Pyridine and pyrimidine derivatives as mglur2 antagonists
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
NZ722345A (en) * 2014-02-14 2018-02-23 Inception 2 Inc Pyrazolone compounds and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122319C (cs) * 1961-06-20
IE903879A1 (en) * 1989-10-30 1991-05-08 Hoffmann La Roche Use of a benzodiazepine and a phenylpyrrylketone derivative

Also Published As

Publication number Publication date
FI915915L (fi) 1992-06-18
IL100364A0 (en) 1992-09-06
ZA919850B (en) 1992-08-26
JPH04275287A (ja) 1992-09-30
IS3792A7 (is) 1992-06-18
IE914369A1 (en) 1992-06-17
EP0491218A1 (en) 1992-06-24
MX9102580A (es) 1992-06-01
KR920012070A (ko) 1992-07-25
CS381891A3 (en) 1992-07-15
CA2057646A1 (en) 1992-06-18
PT99821A (pt) 1992-12-31
FI915915A7 (fi) 1992-06-18
YU194691A (sh) 1994-01-20
HU913960D0 (en) 1992-02-28
BR9105406A (pt) 1992-08-25
HUT59920A (en) 1992-07-28
FI915915A0 (fi) 1991-12-16
NO914968D0 (no) 1991-12-16
CN1062528A (zh) 1992-07-08
AU8974191A (en) 1992-06-18

Similar Documents

Publication Publication Date Title
FI932069A0 (fi) Injektionsspruta
FI930433L (fi) Bitminnescell
FI930077A0 (fi) Oxamider
FI925030L (fi) Iontoforetisk administreringsanordning
FI932690A0 (fi) Tereftalsyras kopolyamider
FI931366L (fi) Foerbaettrade schampokompositioner
FI931976A0 (fi) Samlat koncentriskt tangentialbraennsystem
FI931369A0 (fi) Flytande detergentkompositioner
FI931514L (fi) Rengoeringsanordning foer roerledningar
FI930058L (fi) O-glykolyserad alfa-ifn
FI934577L (fi) Skyddshylsa foer envaegsventil
NO914968D0 (no) Benzodiazepinoner
FI932324L (fi) Gelbildande flytande naeringsfibersammansaettning
FI931225A0 (fi) Milda shampokompositioner
FI931457L (fi) Aprotininanaloger
FI932833A0 (fi) Koppling foer flaensroer
FI915674A0 (fi) Kalliopultituslaite
DE59107143D1 (de) N-Heteroaryl-2-nitroaniline
DK174891A (da) Benzodiazepinderivater
FI931157A0 (fi) 5-trifluoracylamino-2-aryloxatzoler
FI925356A0 (fi) Fastspaenningslock foer rullningshylsor
FI931702A0 (fi) Indenoindolefoereningar
FI925611A0 (fi) Heterocykliska antracyklidon- och antracyklinanaloger
FI931749A0 (fi) Nytt isomerisationsenzym
ATA80690A (de) Alpinschi